Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 8:5:2832.
doi: 10.12688/f1000research.10327.2. eCollection 2016.

Candida antifungal drug resistance in sub-Saharan African populations: A systematic review

Charlene Wilma Joyce Africa  1 , Pedro Miguel Dos Santos Abrantes  1
Affiliations

Candida antifungal drug resistance in sub-Saharan African populations: A systematic review

Charlene Wilma Joyce Africa et al. F1000Res. .

Abstract

Background: Candida infections are responsible for increased morbidity and mortality rates in at-risk patients, especially in developing countries where there is limited access to antifungal drugs and a high burden of HIV co-infection. Objectives: This study aimed to identify antifungal drug resistance patterns within the subcontinent of Africa. Methods: A literature search was conducted on published studies that employed antifungal susceptibility testing on clinical Candida isolates from sub-Saharan African countries using Pubmed and Google Scholar. Results: A total of 21 studies from 8 countries constituted this review. Only studies conducted in sub-Saharan Africa and employing antifungal drug susceptibility testing were included. Regional differences in Candida species prevalence and resistance patterns were identified. Discussion: The outcomes of this review highlight the need for a revision of antifungal therapy guidelines in regions most affected by Candida drug resistance. Better controls in antimicrobial drug distribution and the implementation of regional antimicrobial susceptibility surveillance programmes are required in order to reduce the high Candida drug resistance levels seen to be emerging in sub-Saharan Africa.

Keywords: Africa; Candida; antifungal drug resistance.

PubMed Disclaimer

Conflict of interest statement

Competing interests: No competing interests were disclosed. Competing interests: No competing interests were disclosed. Competing interests: No competing interests were disclosed.

References

    1. Akpan A, Morgan R: Oral candidiasis. Postgrad Med J. 2002;78(922):455–9. 10.1136/pmj.78.922.455 - DOI - PMC - PubMed
    1. Jabra-Rizk MA, Falkler WA, Jr, Enwonwu CO, et al. : Prevalence of yeast among children in Nigeria and the United States. Oral Microbiol Immunol. 2001;16(6):383–5. 10.1034/j.1399-302X.2001.160611.x - DOI - PubMed
    1. Owotade FJ, Patel M, Ralephenya TR, et al. : Oral Candida colonization in HIV-positive women: associated factors and changes following antiretroviral therapy. J Med Microbiol. 2013;62(Pt 1):126–32. 10.1099/jmm.0.047522-0 - DOI - PubMed
    1. Gudlaugsson O, Gillespie S, Lee K, et al. : Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37(9):1172–7. 10.1086/378745 - DOI - PubMed
    1. Almirante B, Rodríguez D, Park BJ, et al. : Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43(4):1829–35. 10.1128/JCM.43.4.1829-1835.2005 - DOI - PMC - PubMed

LinkOut - more resources